Dr. Runaas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 608-263-7350- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
University of Wisconsin School of Medicine & Public HealthClass of 2010
Certifications & Licensure
WI State Medical License 2012 - 2025
MI State Medical License 2014 - 2018
Clinical Trials
- Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease Start of enrollment: 2020 Mar 01
Publications & Presentations
PubMed
- A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Karen Carlson, Laura Michaelis, Lyndsey Runaas, Arielle Baim, Alex Hi...> ;Haematologica. 2024 Apr 4
- Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogen...Chhabra, S., Jerkins, J., Monahan, K., Szabo, A., Shah, N., Abedin, S., Runaas, L., Fenske, T., Pasquini, M., Shaw, B., Drobyski, W., Saber, W., D'Souza, A., Dhakal, B...> ;Bone Marrow Transplantation. 2024 Mar 1
- Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiv...Skyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, Laura C Michaelis, Karen Carlson, Ehab L Atallah, Sameem M Abedin> ;Leukemia Research. 2023 Sep 1
- Join now to see all
Abstracts/Posters
- A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)Lyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lintuzumab Ac-225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML: Interim Results of a Phase I StudyLyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Systematic Screening for Familial Leukemia Based on Somatic Genomic Profiling Results2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hospital Affiliations
Froedtert and the Medical College of Wisconsin Froedtert HospitalMilwaukee, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
